Browse the corpus

Many respiratory conditions produce characteristic abnormalities on chest examination, making lung auscultation a valuable component of the initial evaluation of symptoms such as dyspnea, cough, hypoxia, or chest pain. Egophony is a classic abnormal auscultatory finding characterized by increased resonance and altered transmission of voice sounds. When a patient is asked to say the vowel sound E, the examiner may hear a nasal, A-like sound, often described as the bleating of a goat. Egophony most commonly occurs in settings such as pneumonia or pleural effusion, where normally air-filled lung tissue becomes consolidated, allowing higher-frequency sound waves to transmit more efficiently. Accurate performance and interpretation of chest auscultation findings enable clinicians to link physical examination findings to underlying pathophysiology, improving diagnostic accuracy and informing timely clinical decisions. These skills are particularly important in early patient encounters, resource-limited environments, and situations requiring rapid bedside assessment. This activity is designed to enhance clinicians' bedside diagnostic skills and clinical confidence. Participants refine techniques for assessing voice transmission and learn to reliably identify egophony while distinguishing it from related findings such as bronchophony and whispered pectoriloquy. Learners also develop a clearer understanding of how lung consolidation and pleural pathology alter sound transmission, supporting earlier recognition of conditions such as pneumonia and pleural effusion. By reinforcing the diagnostic value of the physical examination, this activity promotes more thoughtful use of imaging, supports sound clinical reasoning, and enhances patient-centered care through timely diagnosis, appropriate escalation, and effective bedside communication across diverse clinical settings. Objectives: Identify egophony during lung auscultation and recognize its clinical significance in patients with respiratory symptoms. Differentiate egophony from related auscultatory findings such as bronchophony and whispered pectoriloquy. Evaluate the diagnostic value and limitations of egophony compared with other physical examination findings in respiratory disease.

Identify egophony during lung auscultation and recognize its clinical significance in patients with respiratory symptoms. Differentiate egophony from related auscultatory findings such as bronchophony and whispered pectoriloquy. Evaluate the diagnostic value and limitations of egophony compared with other physical examination findings in respiratory disease. Collaborate with members of the interprofessional healthcare team to accurately identify and interpret egophony during the bedside lung examination, integrate auscultatory findings with clinical data, and coordinate timely diagnostic and management decisions to improve patient-centered outcomes. Access free multiple choice questions on this topic.

Despite advances in diagnostic imaging and technology, physical examination of the respiratory system remains a cornerstone in the evaluation of respiratory disease. Chest auscultation is a safe, noninvasive, cost-effective technique that often reveals abnormalities associated with common pulmonary conditions.[1] Egophony is an abnormal auscultatory finding characterized by increased resonance and altered transmission of voice sounds heard over the lungs. When a patient is asked to say the vowel sound E, the examiner hears a nasal, A-like sound, classically described as resembling the bleating of a goat. This phenomenon, also referred to as the E-to-A change, reflects an alteration in the timbre of the transmitted voice.[2] Egophony occurs when normal air-filled lung tissue becomes consolidated, compressed, or surrounded by fluid. Under normal conditions, air within the alveoli dampens sound transmission.[1]  In contrast, consolidation or compression of lung tissue alters acoustic properties by selectively transmitting certain sound frequencies. As a result, the lower-frequency components of the spoken vowel E are attenuated, whereas higher-frequency components are preferentially transmitted, causing the perceived transformation to an A sound. With pulmonary consolidation, such as pneumonia, the dense inflammatory exudate creates a medium that enhances transmission of higher-frequency sounds, producing egophony over the affected area. Likewise, in patients with pleural effusion, fluid accumulation in the pleural space compresses the adjacent lung parenchyma, thereby altering sound conduction (see Image. Consolidation and Pleural Effusion). Clinicians characteristically appreciate egophony at the upper margin of a pleural effusion, where compressed lung tissue borders the fluid layer. Recognizing egophony allows healthcare professionals to correlate physical examination findings with underlying pathology and supports the timely diagnosis of conditions such as pneumonia and pleural effusion.

Egophony is a classic auscultatory finding characterized by an alteration in the quality of transmitted voice sounds during lung examination, in which a spoken E is heard as a nasal A. This finding occurs when normally air-filled lung tissue becomes consolidated or compressed, most commonly in conditions such as pneumonia or at the upper border of a pleural effusion. The consolidated lung preferentially transmits higher-frequency sound vibrations, allowing voice sounds to be heard more clearly and with altered resonance. Although egophony is an infrequent finding, it is highly specific and, when present, significantly increases diagnostic confidence for focal lung pathology. As a bedside, low-cost, and noninvasive maneuver, egophony remains a valuable adjunct to modern diagnostic evaluation when integrated with clinical context and other examination findings. Effective use of egophony requires coordinated skills and strategies across the interprofessional healthcare team. Clinicians and advanced practitioners apply auscultatory findings within clinical reasoning to guide diagnostic prioritization, imaging decisions, and early treatment. Nurses play a critical role in identifying respiratory changes, reporting abnormal breath sounds, and reinforcing timely reassessment. Pharmacists contribute by aligning antimicrobial therapy and supportive medications with suspected pulmonary diagnoses, improving safety and therapeutic effectiveness. Respiratory therapists and other healthcare professionals support comprehensive pulmonary assessment and monitoring. Clear interprofessional communication ensures that abnormal physical findings such as egophony are accurately conveyed, contextualized, and acted upon. Coordinated care enhances patient-centered outcomes by promoting earlier diagnosis, reducing unnecessary testing, improving patient understanding at the bedside, and strengthening team performance through shared clinical awareness and collaboration.